欧罗拉生物科技

2019精准医疗暨离子通道论坛

地点:加拿大不列颠温哥华

时间:2019年7月24-26日

关于会议*

在过去的16年中,精准医疗暨离子通道论坛(PMICR)已发展成为药物开发,基因组学和离子通道研究的重要会议之一。第17届PMICR将继续保持这种优秀的传统,致力于提供探索世界各地尖端技术和创新研究的平台。这种多样化的活动使学术界和行业研究人员能够分享知识,交换意见并建立富有成效的伙伴关系。会议旨在最大限度地提供愉悦和轻松的交流氛围。

会议议题*

*议题有可能发生变化,以实际公布为准。

Precision Medicine Sessions

  1. Key Methodologies in Precision Medicine for Drug Discovery
  2. Next-Generation Sequencing – Applications and Advancement of Genomic Medicine
  3. Immunotherapy for Personalized Medicine
  4. Cancer Care, Diagnosis & Treatment
  5. Microarray and Microfluidic Technologies: Potential in Medicine & Diagnostics
  6. Latest Applications of Liquid Biopsy Research
  7. Stem Cells and Drug Development

Ion Channel Sessions

  1. Key Methodologies in Ion Channel Research for Drug Discovery
  2. Cardiac Safety, CiPA and its impact on drug discovery
  3. Role of Ion Channels in Cancer Treatment
  4. Ion Channels as Pain Targets
  5. Ion Channels as Disease Targets: Alzheimer and Neurodegenerative disease, ALS, Cystic Fibrosis, Epilepsy, Infectious disease
  6. Emerging Areas of Ion Transporter Research
  7. Ion Channels & Immune System

部分与会嘉宾*

  • Aaron McMurtray, M.D., Ph.D.- Associate Clinical Professor of Neurology, David Geffen School of Medicine at University of California; Los Angeles
  • Andrea Ghetti, Ph.D.- Chief Executive Officer at AnaBios Corporation
  • Annarosa Arcangeli, Ph.D.- Professor in the Department of Experimental and Clinical Medicine at University of Florence
  • Chris Mathes, Ph.D.- Chief Commercial Officer at AnaBios Corporation
  • Christine Beeton, Ph.D.- Graduate Program Director of Biomedical Sciences and Associate Professor in the Department of Molecular Physiology and Biophysics at Baylor College of Medicine
  • David Hackos, Ph.D.- Senior Scientist at Genentech, Inc.
  • David Smith, Ph.D.- Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic
  • Elena Dragicevic, Ph.D. – Alliance Manager at Nanion Technologies GmbH
  • Eric Nisenbaum, Ph.D.- Senior Director CNS Research at Alkermes
  • Fernanda Laezza, M.D., Ph.D.- Graduate Program Director and Associate Professor in the Department of Pharmacology and Toxicology at the University of Texas Medical Branch
  • Filip Van Petegem, Ph.D.- Professor in the Department of Biochemistry and Molecular Biology at University of British Columbia
  • Georg Terstappen, Ph.D.- Chief Scientific Officer at OxStem
  • Hailong An, Ph.D.- Deputy Director and Professor in the Institute of Biophysics at Hebei University of Technology
  • Isabelle Deschenes, Ph.D.- Professor of Medicine, Physiology & Biophysics and Biomedical Engineering at Case Western Reserve University
  • James L. Ellis, Ph.D.- Chief Scientific Officer at Nocion Therapeutics
  • Jinwei Zhang, Ph.D.- Principal Investigator in the Laboratory of Molecular Biology at National Institute of Health
  • Jonathan Davila, Ph.D.- Chief Executive Officer and Co-Founder at Neucyte
  • Jonas Korlach, Ph.D.- Chief Scientific Officer at Pacific Biosciences
  • JP Johnson, Ph.D.- Vice President, Biology at Xenon Pharmaceuticals Inc.
  • Khaled Barakat, Ph.D.- Assistant Professor in the Faculty of Pharmacy and Pharmaceutical Sciences at University of Alberta
  • Kevin Foskett, Ph.D.- Isaac Ott Professor of Physiology at University of Pennsylvania
  • Laura Hilton, Ph.D.- Postdoctoral Fellow at Simon Fraser University
  • Marc Pourrier, Ph.D.- Vice President, Operations at IonsGate
  • Marc Rogers, Ph.D.- Chief Scientific Officer at Metrion Biosciences
  • Marzia Martina, Ph.D.- Team Leader, Electrophysiology in Human Health Therapeutics at National Research Council of Canada
  • Merritt Maduke, Ph.D.- Associate Professor of Molecular and Cellular Physiology at Stanford University
  • Michelina Iacovino, Ph.D.- Assistant Professor in the Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles
  • Mohamed Chahine, Ph.D.- Professor in the Department of Medicine at Laval University and CERVO Brain Research Centre
  • Najah Abi-Gerges, Ph.D.- Vice President, Research & Development at AnaBios Corporation
  • Oleg Yerstein, Ph.D.- Postdoctoral Fellow in the Department of Neurology, David Geffen School of Medicine at University of California; Los Angeles
  • Owen McManus, Ph.D.- Chief Technology Officer at Q-State Biosciences
  • Paul C.H. Li, Ph.D.- Professor in the Department of Chemistry at Simon Fraser University
  • Samir Hanash, Ph.D.- Director, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center
  • Stefan Feske, M.D., Ph.D.- Jeffrey Bergstein Professor of Medicine and Director of the Ion Channel & Immunity Program at New York University School of Medicine
  • Terry Snutch, Ph.D.- Professor and the Canada Research Chair in Biotechnology and Genomics- Neurobiology at University of British Columbia
  • Tzyh-Chang Hwang, M.D., Ph.D.- Professor in the Department of Medical Pharmacology and Physiology at University of Missouri
  • Wayne Giles, Ph.D.- Professor in the Faculty of Kinesiology at University of Calgary
  • Xiaoliang Wang, Ph.D.- Director of the Institute of Pharmacology at Chinese Academic of Medical Sciences
  • Yan Xu, Ph.D.- Peter Winter Professor of Anesthesiology & Perioperative Medicine at University of Pittsburgh
  • Yingji Li, Ph.D.- Vice President and Founder of ICE Bioscience
  • Yuji Imaizumi, Ph.D.- Professor in the Department of Molecular and Cellular Pharmacology at Nagoya City University
  • Zhiyuan Li, Ph.D.- Principal Investigator at Guangzhou Institutes of Biomedicine and Health

会议地点及酒店信息**

Sheraton Vancouver Wall Center
1088 Burrard Street, Vancouver
British Columbia, Canada, V6Z 2R9
Tel: +1 (604) 331-1000
https://www.marriott.com/hotels/travel/yvrws-sheraton-vancouver-wall-centre/

We have arranged discounted pricing at this hotel. You can book accommodation online or by calling their toll free number +1-888-236-2427 and requesting the Aurora Biomed Conference rate.

Last Day to Book at discounted rate: Tuesday, July 2, 2019

Room pricing: $319 CAD/ night

往期嘉宾*

  • Craig JanuaryMD, PhD – Professor at the School of Medicine and Public Health, at the University of Wisconsin
  • William CatterallPhD – Professor and Chair of University of Washington Department of Pharmacology
  • Arthur BrownPhD – CEO of MemChan; former founder & CEO of ChanTest
  • Yuko SekinoPhD – Director of Pharmacology National Institute of Health Sciences, Japan
  • Edward StevensPhD – Head of Electrophysiology at Pfizer, Cambridge, UK
  • Dennis LoMD, PhD – Associate Dean, Faculty of Medicine at CUHK, Foreign Associate US Academy of Sciences
  • George Chandy, MD, PhD – Professor at NTU SG and UC Irvine
  • Kurt Stoeckli – President & CSO at Glenmark Pharmaceuticals, Switzerland
  • Hailin Zhang, MD, PhD – Vice President of Hebei Medical University
  • Richard OlsenPhD – Distinguished Professor of Neuroscience at the David Geffen School of Medicine at UCLA
  • Yuklam Lo – Secretariat, and Honorary Chairman, Hong Kong Biotechlogy Organization
  • An Hailong – Hebei University of Technology; Professor
  • Dan MinorPhD – Professor, Biochemistry and Biophysics, Cellular and Molecular Pharmacology, University of California
  • Steve GoldsteinMD, PhD – Director at the Institute of Pediatric Sciences, University of Chicago
  • John DunlopPhD – VP, Neuroscience Research at Amgen, Professor of Neuroscience, University of St Andrews
  • Laszlo UrbanMD, PhD – Executive Director at Novartis
  • Jean-Pierre ValentinPhD – Senior Director, Head of Investigative Toxicology at UCB

论文征集将于2019年5月24日截止。请有意向参加会议演讲的代表抓紧时间提交摘要登记注册

赞助商*

合作媒体*